# China NMPA Drug Inspection - Xiangbei Wellman Pharmaceutical Co., Ltd. - Amoxicillin Clavulanate Potassium Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/xiangbei-wellman-pharmaceutical-co-ltd/5821ef54-3b86-4050-936c-5a5de05ef652/
Source feed: China

> China NMPA drug inspection for Xiangbei Wellman Pharmaceutical Co., Ltd. published July 28, 2022. Drug: Amoxicillin Clavulanate Potassium Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Xiangbei Wellman Pharmaceutical Co., Ltd.
- Publication Date: 2022-07-28
- Drug Name: Amoxicillin Clavulanate Potassium Tablets
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/xiangbei-wellman-pharmaceutical-co-ltd/1adf8beb-b9df-4cd3-902c-cba4e855ec39/